The successful cooperation between Beiguang Jingyi Company and Mongolian Medicine Co., Ltd. in the field of TOC total organic carbon analyzer reflects the deep integration of technology research and development with the national pharmaceutical industry.

Technical background
The TOC analyzer independently developed by Beiguang Jingyi adopts conductivity difference detection technology, which has the characteristics of high accuracy (± 4%) and fast response (within 4 minutes), and is suitable for online and offline detection of pharmaceutical water (including injection water and ultrapure water). Its products comply with the standards of the Chinese Pharmacopoeia, support IQ/OQ/PQ services, and are equipped with touch screen operation, data storage, and alarm functions.

Opportunities for cooperation
Inner Mongolia Autonomous Region is promoting the development of the entire Mongolian medicine industry chain, including standardization construction and improvement of inspection and testing capabilities. The "Inspection and Testing Promotion of Industrial Upgrading Action" carried out by the Autonomous Region Market Supervision Bureau also provides policy support for such technological cooperation. The TOC analyzer technology of Beiguang Jingyi may be integrated with Mongolian pharmaceutical companies through such platforms to meet their pharmaceutical water quality control needs.

Application scenarios
This instrument can detect organic carbon in the range of 0.001mg/L to 1.5mg/L, and is suitable for monitoring and cleaning validation of purified water and injection water in Mongolian medicine production. Its portable design facilitates on-site sampling and meets the needs of the Mongolian medicine industry for efficient and accurate testing.

Background of policy and industry synergy
Inner Mongolia Autonomous Region is promoting the development of the entire Mongolian medicine industry chain, including standardization construction and improvement of inspection and testing capabilities. The Autonomous Region Food and Drug Administration, in collaboration with the platform, is promoting the "Smart Drug Testing" project, strengthening collaborative innovation between production and research, and providing policy support for technological cooperation. In addition, the implementation of the "Implementation Rules for the Filing Management of Traditional Chinese Medicine (Mongolian Medicine) Preparations Prepared by Medical Institutions in Inner Mongolia Autonomous Region" has further standardized the production process of Mongolian medicine preparations and put forward higher requirements for the technical adaptability of testing equipment.

This cooperation may provide key technical support for the standardization and modernization of Mongolian medicine production, further promoting the upgrading of the ethnic medicine industry.